Syros Pharmaceuticals Inc (OTCPK:SYRS)
$ 0.00010 (0%) Market Cap: 3,000.00 Enterprise Value: 1.95 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 12/100

Q1 2019 Syros Pharmaceuticals Inc Earnings Call Transcript

May 01, 2019 / 12:30PM GMT
Release Date Price: $71.7 (-0.83%)
Operator

Good morning and welcome to Syros Pharmaceuticals' First Quarter 2019 Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investor & Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. (Operator Instructions) At this time, I would like to turn the call over to Naomi Aoki, Vice President of Corporate Communications and Investor Relations at Syros.

Naomi Aoki
Syros Pharmaceuticals, Inc. - VP of Corporate Communications & IR

Thank you. This morning, we issued a press release with our first quarter 2019 financial results, along with the anticipated future milestones and recent accomplishments. This release is available on the Investors & Media section of Syros' website at www.syros.com.

We'll begin the call with prepared remarks by Dr. Nancy Simonian, our Chief Executive Officer; and Joe Ferra, our Chief Financial Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot